CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.
about
New adjuvanted vaccines in pregnancy: what is known about their safety?Short- and long-term changes in gene expression mediated by the activation of TLR9The Key Events Dose-Response Framework: its potential for application to foodborne pathogenic microorganismsTLR-based immune adjuvants.Animal models of listeriosis: a comparative review of the current state of the art and lessons learned.Tweaking Innate Immunity: the Promise of Innate Immunologicals As Anti-infectivesImmune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.From mice to women: the conundrum of immunity to infection during pregnancy.TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.Exposure to stimulatory CpG oligonucleotides during gestation induces maternal hypertension and excess vasoconstriction in pregnant rats.Effect of Calcium Carbonate Encapsulation on the Activity of Orally Administered CpG OligonucleotidesContribution of nitric oxide to CpG-mediated protection against Listeria monocytogenes.Expression of toll-like receptors in the Fusarium solani infected cornea.Antibiotic administration to patients with preterm labor and intact membranes: is there a beneficial effect in patients with endocervical inflammation?Association of self-DNA mediated TLR9-related gene, DNA methyltransferase, and cytokeratin protein expression alterations in HT29-cells to DNA fragment length and methylation status.
P2860
Q30396657-FB48EBF8-10DB-4106-B813-4DEB36EDBB7DQ33695664-C1CA7B04-9D28-4BE0-8F98-2D75F22BAA5DQ33736235-BE55C9F3-B973-4BF9-B134-892F01B4F527Q34400322-9ACDFDA3-EC05-4196-99DF-480612AE0C7BQ36062235-4B33B104-CF1C-4490-B08A-CCEC4DBB92FBQ36171257-232041C4-52A3-4827-A98A-F8E89805CBEAQ36526351-2472B8A6-BE44-41E4-8F02-05A57EAFDA7CQ37108435-52461104-712E-4599-A22B-600B96254F11Q37447389-CF662A04-CA08-4F49-A7D2-5FC1A44B4CD9Q40792782-73FC8928-F940-47E1-A3EF-EAD4E3A31B47Q41003483-32243050-F58A-4A0B-AC2C-E63AE08CF878Q42151564-E8BDD8DD-92FD-436B-83F6-5DDE3EE596CFQ45017399-31ACF7BB-E9F2-462F-B8E7-21D7F8F73C55Q46341090-C1E150EA-17CA-49EE-84D5-377E55CED8BAQ54331419-8FC5E162-F849-4508-B2F0-F98B83A16F92
P2860
CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@ast
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@en
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@nl
type
label
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@ast
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@en
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@nl
prefLabel
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@ast
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@en
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@nl
P2093
P2860
P1476
CpG oligodeoxynucleotides impr ...... teria monocytogenes infection.
@en
P2093
Dennis M Klinman
Hidekazu Shirota
Shu-ichi Ito
P2860
P304
P356
10.1128/IAI.72.6.3543-3548.2004
P407
P50
P577
2004-06-01T00:00:00Z